Abstract

Cisplatin has been frequently used for treatment of wide variety of tumors. The use of cisplatin is associated with severe cytotoxicity such as nephrotoxicity, hepatotoxicity and spermiotoxicity which radically limits its clinical use. The present study aimed to investigate the possible protective effects of multiple doses of hesperidin against cisplatin-induced nephrotoxicity induced by single i.p injection of cisplatin (7.5 mg/kg). Hesperidin was given to rats at two different doses (100 and 200 mg/kg p.o) for 7 days starting one day before cisplatin injection. Blood samples were collected for determination of serum creatinine and Blood Urea Nitrogen (BUN) levels. Kidneys were used for the determination of Malondialdehyde (MDA), Glutathione (GSH) and total nitrate and nitrite contents. Liver samples were also used for histopathological examination. Results showed that hesperidin significantly reduced cisplatin-induced elevations in serum creatinine and BUN levels. It also significantly reduced kidney MDA and NO content and elevated GSH content. In conclusion, hesperidin greatly protected kidney against cisplatin-induced toxicity in a dose-dependent manner.

Keywords:

Blood urea nitrogen, cisplatin, creatinine, hesperidin, nephrotoxicity, oxidative stress,

References

1. Abdelmeguid, N.E., H.N. Chmaisse and N.S. Abou Zeinab, 2010a. Silymarin ameliorates cisplatin-induced hepatotoxicity in rats: Histopathological and ultrastructural studies. Pak. J. Biol. Sci., 13(10): 463-479.
   CrossRef    PMid:21848071    
2. Abdelmeguid, N.E., H.N. Chmaisse and N.A. Zeinab, 2010b. Protective effect of silymarin on cisplatin-induced nephrotoxicity in rats. Pakist. J. Nutr., 9(7): 624-636.
   CrossRef    
3. Ahmad, S.T., W. Arjumand, S. Nafees, A. Seth, N. Ali, S. Rashid and S. Sultana, 2012. Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apoptosis and inflammation. Toxicol. Lett., 208(2): 149-161.
   CrossRef    PMid:22093918    
4. Arab, H.H., S.A. Salama, A.H. Eid, H.A. Omar, S.A. Arafa el and I.A. Maghrabi, 2014. Camel's milk ameliorates TNBS-induced colitis in rats via downregulation of inflammatory cytokines and oxidative stress. Food Chem. Toxicol., 69: 294-302.
   CrossRef    PMid:24788059    
5. Atessahin, A., I. Karahan, G. Turk, S. Gur, S. Yilmaz and A.O. Ceribasi, 2006. Protective role of lycopene on cisplatin-induced changes in sperm characteristics, testicular damage and oxidative stress in rats. Reprod. Toxicol., 21(1): 42-47.
   CrossRef    PMid:15979841    
6. Bancroft, J.D., A. Stevens and D.R. Turner, 1996.Theory and Practice of Histological Techniques.4th Edn., Churchill Livingstone,New York, London, San Francisco, Tokyo.
   
7. Beutler, E., O. Duron and B.M. Kelly, 1963. Improved method for the determination of blood glutathione. J. Lab. Clin. Med., 61: 882-888.
   
8. Cayir, K., A Karadeniz, A. Yildirim, Y. Kalkan, A. Karakoc, M. Keles and S.B. Tekin, 2009. Protective effect of L-carnitine against cisplatin-induced liver and kidney oxidant injury in rats. Cent. Eur.J. Med., 4(2): 184-191.
   CrossRef    
9. Chirino, Y., R.Hernández-Pando, J. Pedraza-Chaverrí 2004. Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol., 4(1): 20.
   CrossRef    PMid:15458572 PMCid:PMC526185    
10. Cohen, S.M. and S.J. Lippard, 2001. Cisplatin: From DNA damage to cancer chemotherapy. Prog. Nucl. Acid Res. Mol. Biol., 67: 93-130.
    CrossRef    
11. Comelli, M.C., U. Mengs, C. Schneider and M. Prosdocimi, 2007. Toward the definition of the mechanism of action of silymarin: Activities related to cellular protection from toxic damage induced by chemotherapy. Integr. Cancer Ther., 6(2): 120-129.
    CrossRef    PMid:17548791    
12. Cotelle, N., J.L. Bernier, J.P. Catteau, J. Pommery, J.C. Wallet and E.M. Gaydou, 1996. Antioxidant properties of hydroxy-flavones. Free Radic. Biol Med., 20(1): 35-43.
    CrossRef    
13. Dashti-Khavidaki, S., F. Shahbazi, H. Khalili and M. Lessan-Pezeshki, 2012. Potential renoprotective effects of silymarin against nephrotoxic drugs: A review of literature. J. Pharm. Pharm. Sci., 15(1): 112-123.
    CrossRef    PMid:22365093    
14. Fraga, C.G., V.S. Martino, G.E. Ferraro, J.D. Coussio and A. Boveris, 1987. Flavonoids as antioxidants evaluated by< i> in vitro and< i> in situ liver chemiluminescence. Biochem.Pharmacol., 36(5): 717-720.
    CrossRef    
15. Gaedeke, J., L.M. Fels, C. Bokemeyer, U. Mengs, H. Stolte and H. Lentzen, 1996. Cisplatin nephrotoxicity and protection by silibinin. Nephrol. Dial. Transplant., 11(1): 55-62.
    CrossRef    PMid:8649653    
16. Garg, A., S. Garg, L.J. Zaneveld and A.K. Singla, 2001. Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother. Res., 15(8): 655-669.
    CrossRef    PMid:11746857    
17. Goldstein, R.S.and G.H. Mayor, 1983. Minireview. The nephrotoxicity of cisplatin. Life Sci., 32(7): 685-690.
    CrossRef    
18. Hakova, H., E. Misurova and K. Kropacova, 1996. The effect of silymarin on concentration and total content of nucleic acids in tissues of continuously irradiated rats. Vet. Med. (Praha), 41(4): 113-119.
    
19. Haller, C. and I. Hizoh, 2004. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest. Radiol., 39(3): 149-154.
    CrossRef    PMid:15076007    
20. Hussein, A., A.A. Ahmed, S.A. Shouman and S. Sharawy, 2012. Ameliorating effect of DL-alpha-lipoic acid against cisplatin-induced nephrotoxicity and cardiotoxicity in experimental animals. Drug Discov. Ther., 6(3): 147-156.
    PMid:22890205    
21. Iraz, M., E. Ozerol, M. Gulec, S. Tasdemir, N. Idiz, E. Fadillioglu, M. Naziroglu and O. Akyol, 2006. Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat. Cell Biochem. Funct., 24(4): 357-361.
    CrossRef    PMid:16437419    
22. Jean, T. and M.C. Bodinier, 1994. Mediators involved in inflammation: effects of Daflon 500 mg on their release. Angiology, 45(6 Pt 2): 554-559.
    PMid:8203787    
23. Justesen, U., P. Knuthsen and T. Leth, 1998. Quantitative analysis of flavonols, flavones and flavanones in fruits, vegetables and beverages by high-performance liquid chromatography with photo-diode array and mass spectrometric detection. J. Chromatogr. A, 799(1-2): 101-110.
    CrossRef    
24. Karadeniz, A., N. Simsek, E. Karakus, S. Yildirim, A. Kara, I. Can, F. Kisa, H. Emre and M. Turkeli, 2011. Royal jelly modulates oxidative stress and apoptosis in liver and kidneys of rats treated with cisplatin. Oxid. Med. Cell Longev., 2011: 981793.
    CrossRef    PMid:21904651 PMCid:PMC3166579    
25. Karimi, G., M. Ramezani and Z. Tahoonian, 2005. Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evid.-Based Compl. Alt., 2(3): 383-386.
    CrossRef    PMid:16136217 PMCid:PMC1193544    
26. Karimi, G., M. Vahabzadeh, P. Lari, M. Rashedinia and M. Moshiri, 2011. "Silymarin": A promising pharmacological agent for treatment of diseases. Iran J. Basic Med. Sci., 14(4): 308-317.
    PMid:23492971 PMCid:PMC3586829    
27. Kaur, G., N. Tirkey and K. Chopra, 2006. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicology, 226(2-3): 152-160.
    CrossRef    PMid:16919860    
28. Kawai, Y., T. Nakao, N. Kunimura, Y. Kohda and M. Gemba, 2006. Relationship of intracellular calcium and oxygen radicals to Cisplatin-related renal cell injury. J. Pharmacol. Sci., 100(1): 65-72.
    CrossRef    PMid:16410676    
29. Lee, K.H., M.H. Yeh, S.T. Kao, C.M. Hung, C.J. Liu, Y.Y. Huang and C.C. Yeh, 2010. The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kappaB in human hepatocellular carcinoma cells. Toxicol. Lett., 194(1-2): 42-49.
    CrossRef    PMid:20138977    
30. Loguercio, C. and A. Federico, 2003. Oxidative stress in viral and alcoholic hepatitis. Free Radic. Biol. Med., 34(1): 1-10.
    CrossRef    
31. Mansour, H.H., H.F. Hafez and N.M. Fahmy, 2006. Silymarin modulates Cisplatin-induced oxidative stress and hepatotoxicity in rats. J. Biochem. Mol. Biol., 39(6): 656-661.
    CrossRef    PMid:17129399    
32. Mehany, H.A., A.M. Abo-Youssef, L.A. Ahmed, E.S.A. Arafa and H.A.A. El-Latif, 2013. Protective effect of vitamin E and atorvastatin against potassium dichromate-induced nephrotoxicity in rats. Beni-Suef Univ. J. Basic Appl. Sci., 2(2): 96-102.
    
33. Mihara, M. and M. Uchiyama, 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem., 86(1): 271-278.
    CrossRef    
34. Miranda, K.M., M.G. Espey and D.A. Wink, 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nato Sci. S A Lif. Sci., 5(1): 62-71.
    
35. Miyake, Y., K. Yamamoto, N. Tsujihara and T. Osawa, 1998. Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids, 33(7): 689-695.
    CrossRef    PMid:9688172    
36. Morel, I., G. Lescoat, P. Cogrel, O. Sergent, N. Pasdeloup, P. Brissot, P. Cillard and J. Cillard, 1993. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol., 45(1): 13-19.
    CrossRef    
37. Naqshbandi, A., W. Khan, S. Rizwan and F. Khan, 2012. Studies on the protective effect of flaxseed oil on cisplatin-induced hepatotoxicity. Hum. Exp. Toxicol., 31(4): 364-375.
    CrossRef    PMid:22249395    
38. Pabla, N. and Z. Dong, 2008. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney Int., 73(9): 994-1007.
    CrossRef    PMid:18272962    
39. Palipoch, S., C. Punsawad, P. Koomhin and P. Suwannalert, 2014. Hepatoprotective effect of curcumin and alpha-tocopherol against cisplatin-induced oxidative stress. BMC Complem. Altern. M., 14(1): 111.
    CrossRef    PMid:24674233 PMCid:PMC3986848    
40. Prabhu, V.V., N. Kannan and C. Guruvayoorappan, 2013. 1,2-Diazole prevents cisplatin-induced nephrotoxicity in experimental rats. Pharmacol. Rep., 65(4): 980-990.
    CrossRef    
41. Pratibha, R., R. Sameer, P.V. Rataboli, D.A.Bhiwgade and C.Y. Dhume, 2006. Enzymatic studies of cisplatin induced oxidative stress in hepatic tissue of rats. Eur. J. Pharmacol., 532(3): 290-293.
    CrossRef    PMid:16458885    
42. Previati, M., I. Lanzoni, E. Corbacella, S. Magosso, V. Guaran, A. Martini and S. Capitani, 2006. Cisplatin-induced apoptosis in human promyelocytic leukemia cells. Int. J. Mol. Med., 18(3): 511-516.
    CrossRef    
43. Sadowitz, P.D., B.A. Hubbard, J.C. Dabrowiak, J. Goodisman, K.A. Tacka, M.K. Aktas, M.J. Cunningham, R.L. Dubowy and A.K. Souid, 2002. Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs. Drug Metab. Dispos., 30(2): 183-190.
    CrossRef    PMid:11792689    
44. Safirstein, R.L., 1999. Lessons learned from ischemic and cisplatin-induced nephrotoxicity in animals. Ren. Fail, 21(3-4): 359-364.
    CrossRef    PMid:10416214    
45. Sahu, B.D., M. Kuncha, G.J. Sindhura and R. Sistla, 2013. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage. Phytomedicine, 20(5): 453-460.
    CrossRef    PMid:23353054    
46. Saller, R., J. Melzer, J. Reichling, R. Brignoli and R. Meier, 2007. An updated systematic review of the pharmacology of silymarin. Forsch. Komplementmed., 14(2): 70-80.
    CrossRef    
47. Schinella, G., H. Tournier, J. Prieto, P.M. De Buschiazzo and J. R?±os, 2002. Antioxidant activity of anti-inflammatory plant extracts. Life Sci., 70(9): 1023-1033.
    CrossRef    
48. Shi, R., Q. Huang, X. Zhu, Y.B. Ong, B. Zhao, J. Lu, C.N. Ong and H.M. Shen, 2007. Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase-mediated p53 phosphorylation and stabilization. Mol. Cancer Ther., 6(4): 1338-1347.
    CrossRef    PMid:17431112    
49. Shona, S., A.W. Essawy, S.M. Zaki andT.I. Abdel-Galil,2012. Effect of cisplatinum on the liver of the adult albino rat and the possible protective role of vitamin E (Histological and ultrastructural study). Anat. Physiol., 2(3): 1-5.
    CrossRef    
50. Siddik, Z.H., 2003. Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene, 22(47): 7265-7279.
    CrossRef    PMid:14576837    
51. Silici, S., O. Ekmekcioglu, M. Kanbur and K. Deniz, 2011. The protective effect of royal jelly against cisplatin-induced renal oxidative stress in rats. World J. Urol., 29(1): 127-132.
    CrossRef    PMid:20369241    
52. Tirkey, N., S. Pilkhwal, A. Kuhad and K. Chopra, 2005. Hesperidin, a citrus bioflavonoid, decreases the oxidative stress produced by carbon tetrachloride in rat liver and kidney. BMC Pharmacol., 5: 2.
    CrossRef    
53. Tsuruya, K., T. Ninomiya, M. Tokumoto, M. Hirakawa, K. Masutani, M. Taniguchi, K. Fukuda, H. Kanai, K. Kishihara, H. Hirakata and M. Iida, 2003. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int., 63(1): 72-82.
    CrossRef    PMid:12472770    
54. Weijl, N.I., F.J. Cleton and S. Osanto, 1997. Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat. Rev., 23(4): 209-240.
    CrossRef    
55. Weijl, N.I., G.D. Hopman, A. Wipkink-Bakker, E.G. Lentjes, H.M. Berger, F.J. Cleton and S. Osanto, 1998. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann. Oncol., 9(12): 1331-1337.
    CrossRef    PMid:9932164    
56. Zicca, A., S. Cafaggi, M.A. Mariggio, M.O. Vannozzi, M. Ottone, V. Bocchini, G. Caviglioli and M. Viale, 2002. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. Eur. J. Pharmacol., 442(3): 265-272.
    CrossRef    

Competing interests

The authors have no competing interests.

Open Access Policy

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright

The authors have no competing interests.